Print Page  |  Close Window

SEC
8-K
BIOTELEMETRY, INC. filed this Form 8-K on 10/30/2018
Entire Document
 << Previous Page | Next Page >>


Item 2.02 Results of Operations and Financial Condition.
On October 30, 2018, BioTelemetry, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2018. Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. A copy of the press release is included herewith as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number
 
Exhibit Title
 
Press release dated October 30, 2018

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
BioTelemetry, Inc.
 
 
 
 
 
 
 
 
Dated: October 30, 2018
 
By:
/s/ Heather C. Getz
 
 
 
 
 
 
 
Name:
Heather C. Getz
 
 
 
Title:
Executive Vice President and Chief Financial Officer



 << Previous Page | Next Page >>